BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-6.91%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$488M
AUM Growth
+$488M
(-12%)
Cap. Flow
-$19.4M
Cap. Flow
% of AUM
-3.97%
Top 10 Holdings %
Top 10 Hldgs %
32.78%
Holding
126
New
5
Increased
19
Reduced
36
Closed
4
Top Buys
| 1 |
Incyte
INCY
|
$5.96M |
| 2 |
BCR
CR Bard Inc.
BCR
|
$5.86M |
| 3 |
Danaher
DHR
|
$5.76M |
| 4 |
AKRX
Akorn, Inc.
AKRX
|
$4.54M |
| 5 |
Edwards Lifesciences
EW
|
$3.75M |
Top Sells
| 1 |
Cardinal Health
CAH
|
$6.78M |
| 2 |
Illumina
ILMN
|
$5.21M |
| 3 |
AMSG
Amsurg Corp
AMSG
|
$4.79M |
| 4 |
Stryker
SYK
|
$3.04M |
| 5 |
Cigna
CI
|
$2.93M |
Sector Composition
| 1 | Healthcare | 91.87% |
| 2 | Financials | 0.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $23.1M | 4.73% | 199,650 +5,400 | +3% | +$625K |
|
|
2
Stryker
SYK
$150B
| $18.6M | 3.81% | 155,400 -25,400 | -14% | -$3.04M |
|
3
Medtronic
MDT
$119B
| $18.5M | 3.79% | 259,500 +12,000 | +5% | +$855K |
|
4
UnitedHealth
UNH
$281B
| $17.6M | 3.61% | 110,000 +10,800 | +11% | +$1.73M |
|
5
Abbott
ABT
$231B
| $15.6M | 3.19% | 405,500 +21,500 | +6% | +$826K |
|
|
6
Incyte
INCY
$16.5B
| $15.1M | 3.09% | 150,400 +59,400 | +65% | +$5.96M |
|
7
Biogen
BIIB
$19.4B
| $13.9M | 2.85% | 49,000 -5,500 | -10% | -$1.56M |
|
8
Gilead Sciences
GILD
$140B
| $12.9M | 2.63% | 179,500 +23,000 | +15% | +$1.65M |
|
9
Ligand Pharmaceuticals
LGND
$3.15B
| $12.7M | 2.59% | 124,530 +17,650 | +17% | +$1.79M |
|
10
Amgen
AMGN
$155B
| $12.2M | 2.5% | 83,500 | – | – |
|
11
Boston Scientific
BSX
$156B
| $11.9M | 2.44% | 550,000 -25,000 | -4% | -$541K |
|
12
Regeneron Pharmaceuticals
REGN
$61.5B
| $11.9M | 2.43% | 32,300 -5,700 | -15% | -$2.09M |
|
|
13
Edwards Lifesciences
EW
$47.8B
| $11.7M | 2.4% | 125,000 +40,000 | +47% | +$3.75M |
|
|
BCR
14
DELISTED
CR Bard Inc.
BCR
| $11.5M | 2.35% | 51,100 +26,100 | +104% | +$5.86M |
|
15
Zimmer Biomet
ZBH
$21B
| $10.6M | 2.18% | 103,000 +23,000 | +29% | +$2.37M |
|
|
AKRX
16
DELISTED
Akorn, Inc.
AKRX
| $10M | 2.06% | 460,000 +208,000 | +83% | +$4.54M |
|
17
Jazz Pharmaceuticals
JAZZ
$7.75B
| $9.14M | 1.87% | 83,800 | – | – |
|
18
Viatris
VTRS
$12.3B
| $8.99M | 1.84% | 235,700 | – | – |
|
19
Hologic
HOLX
$14.9B
| $8.81M | 1.8% | 219,600 -22,500 | -9% | -$903K |
|
20
Centene
CNC
$14.3B
| $8.57M | 1.75% | 151,630 +10,200 | +7% | +$576K |
|
21
Teva Pharmaceuticals
TEVA
$21.1B
| $8.52M | 1.74% | 234,990 +47,800 | +26% | +$1.73M |
|
22
Baxter International
BAX
$12.7B
| $8.43M | 1.73% | 190,000 | – | – |
|
|
23
Illumina
ILMN
$15.8B
| $6.89M | 1.41% | 53,800 -40,675 | -43% | -$5.21M |
|
24
Becton Dickinson
BDX
$55.3B
| $6.62M | 1.36% | 40,000 -15,000 | -27% | -$2.48M |
|
|
AGN
25
DELISTED
Allergan plc
AGN
| $6.17M | 1.26% | 29,400 | – | – |
|